ReP USP - Resultado da busca

Trabalho de evento-resumo
Multitarget antileukemic effects of metformin in myeloproliferative neoplasm cells: inhibition of JAK2/STAT signaling and mitochondrial activity (2016)
Machado Neto, João Agostinho ; Fenerich, Bruna Alves; Scopim-Ribeiro, Renata; Dechandt, Carlos Roberto Porto; Alves, Ana Paula Nunes Rodrigues; Fernandes, Jaqueline Cristina; Scheucher, Priscila Santos; Simões, Belinda Pinto; Alberici, Luciane Carla; Pontes, Lorena Lôbo de Figueiredo; Rego, Eduardo Magalhães; Traina, Fabiola
Source: Abstracts. Conference titles: Annual Meeting and Exposition of the American Society of Hematology. Unidades: FMRP, FCFRP
Subjects: CLÍNICA GERAL, LEUCEMIA MIELOIDE, INSULINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO NETO, João Agostinho et al. Multitarget antileukemic effects of metformin in myeloproliferative neoplasm cells: inhibition of JAK2/STAT signaling and mitochondrial activity. 2016, Anais.. San Diego: ASH, 2016. Disponível em: http://www.bloodjournal.org/content/128/22/1960. Acesso em: 07 jun. 2024.
APA
Machado Neto, J. A., Fenerich, B. A., Scopim-Ribeiro, R., Dechandt, C. R. P., Alves, A. P. N. R., Fernandes, J. C., et al. (2016). Multitarget antileukemic effects of metformin in myeloproliferative neoplasm cells: inhibition of JAK2/STAT signaling and mitochondrial activity. In Abstracts. San Diego: ASH. Recuperado de http://www.bloodjournal.org/content/128/22/1960
NLM
Machado Neto JA, Fenerich BA, Scopim-Ribeiro R, Dechandt CRP, Alves APNR, Fernandes JC, Scheucher PS, Simões BP, Alberici LC, Pontes LL de F, Rego EM, Traina F. Multitarget antileukemic effects of metformin in myeloproliferative neoplasm cells: inhibition of JAK2/STAT signaling and mitochondrial activity [Internet]. Abstracts. 2016 ;[citado 2024 jun. 07 ] Available from: http://www.bloodjournal.org/content/128/22/1960
Vancouver
Machado Neto JA, Fenerich BA, Scopim-Ribeiro R, Dechandt CRP, Alves APNR, Fernandes JC, Scheucher PS, Simões BP, Alberici LC, Pontes LL de F, Rego EM, Traina F. Multitarget antileukemic effects of metformin in myeloproliferative neoplasm cells: inhibition of JAK2/STAT signaling and mitochondrial activity [Internet]. Abstracts. 2016 ;[citado 2024 jun. 07 ] Available from: http://www.bloodjournal.org/content/128/22/1960
Artigo de periodico
The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms (2016)
Berzoti-Coelho, Maria Gabriela; Ferreira, Aline Fernanda; Nunes, Natalia de Souza; Pinto, Mariana Tomazini; Rocha Júnior, Maurício Cristiano; Simões, Belinda Pinto; Martínez-A, Carlos; Souto, Elizabeth Xisto; Panepucci, Rodrigo Alexandre; Covas, Dimas Tadeu; Kashima, Simone; Castro, Fabíola Attié de
Source: Blood Cells, Molecules, and Diseases. Unidades: FMRP, FCFRP
Subjects: LEUCEMIA MIELOIDE, DOENÇA CRÔNICA, APOPTOSE, TROMBOCITOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERZOTI-COELHO, Maria Gabriela et al. The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms. Blood Cells, Molecules, and Diseases, v. 59, p. 25-30, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2016.03.008. Acesso em: 07 jun. 2024.
APA
Berzoti-Coelho, M. G., Ferreira, A. F., Nunes, N. de S., Pinto, M. T., Rocha Júnior, M. C., Simões, B. P., et al. (2016). The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms. Blood Cells, Molecules, and Diseases, 59, 25-30. doi:10.1016/j.bcmd.2016.03.008
NLM
Berzoti-Coelho MG, Ferreira AF, Nunes N de S, Pinto MT, Rocha Júnior MC, Simões BP, Martínez-A C, Souto EX, Panepucci RA, Covas DT, Kashima S, Castro FA de. The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms [Internet]. Blood Cells, Molecules, and Diseases. 2016 ; 59 25-30.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1016/j.bcmd.2016.03.008
Vancouver
Berzoti-Coelho MG, Ferreira AF, Nunes N de S, Pinto MT, Rocha Júnior MC, Simões BP, Martínez-A C, Souto EX, Panepucci RA, Covas DT, Kashima S, Castro FA de. The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms [Internet]. Blood Cells, Molecules, and Diseases. 2016 ; 59 25-30.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1016/j.bcmd.2016.03.008
Artigo de periodico
Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment (2016)
Galvão, Alyne Fávero; Petta, Tânia; Flamand, Nicolas; Bollela, Valdes Roberto; Silva, Célio Lopes; Jarduli, Luciana Ribeiro; Malmegrim, Kelen Cristina Ribeiro; Simões, Belinda Pinto; Moraes, Luiz Alberto Beraldo de; Faccioli, Lucia Helena
Source: Analytical and Bioanalytical Chemistry. Unidades: FMRP, FFCLRP, FCFRP
Subjects: ANEMIA FALCIFORME, TRANSFUSÃO DE SANGUE, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, EICOSANOIDES, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GALVÃO, Alyne Fávero et al. Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment. Analytical and Bioanalytical Chemistry, v. 408, n. 13, p. 3613-3623, 2016Tradução . . Disponível em: https://doi.org/10.1007/s00216-016-9445-8. Acesso em: 07 jun. 2024.
APA
Galvão, A. F., Petta, T., Flamand, N., Bollela, V. R., Silva, C. L., Jarduli, L. R., et al. (2016). Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment. Analytical and Bioanalytical Chemistry, 408( 13), 3613-3623. doi:10.1007/s00216-016-9445-8
NLM
Galvão AF, Petta T, Flamand N, Bollela VR, Silva CL, Jarduli LR, Malmegrim KCR, Simões BP, Moraes LAB de, Faccioli LH. Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment [Internet]. Analytical and Bioanalytical Chemistry. 2016 ; 408( 13): 3613-3623.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1007/s00216-016-9445-8
Vancouver
Galvão AF, Petta T, Flamand N, Bollela VR, Silva CL, Jarduli LR, Malmegrim KCR, Simões BP, Moraes LAB de, Faccioli LH. Plasma eicosanoid profiles determined by high-performance liquid chromatography coupled with tandem mass spectrometry in stimulated peripheral blood from healthy individuals and sickle cell anemia patients in treatment [Internet]. Analytical and Bioanalytical Chemistry. 2016 ; 408( 13): 3613-3623.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1007/s00216-016-9445-8
Artigo de periodico
Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study (2016)
Castro, Francine Attié de; Scatena, Gabriel dos Santos; Rocha, Otávio Pelegrino; Marques, Maria Paula; Cass, Quézia Bezerra; Simões, Belinda Pinto; Lanchote, Vera Lúcia
Source: Journal of Chromatography B. Unidades: FMRP, FCFRP
Subjects: CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, ESPECTROMETRIA DE MASSAS, REPRODUTIBILIDADE DE RESULTADOS, FARMACOCINÉTICA, REGRESSÃO LINEAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Francine Attié de et al. Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study. Journal of Chromatography B, v. 1011, p. 53-61, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2015.12.049. Acesso em: 07 jun. 2024.
APA
Castro, F. A. de, Scatena, G. dos S., Rocha, O. P., Marques, M. P., Cass, Q. B., Simões, B. P., & Lanchote, V. L. (2016). Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study. Journal of Chromatography B, 1011, 53-61. doi:10.1016/j.jchromb.2015.12.049
NLM
Castro FA de, Scatena G dos S, Rocha OP, Marques MP, Cass QB, Simões BP, Lanchote VL. Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study [Internet]. Journal of Chromatography B. 2016 ; 1011 53-61.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1016/j.jchromb.2015.12.049
Vancouver
Castro FA de, Scatena G dos S, Rocha OP, Marques MP, Cass QB, Simões BP, Lanchote VL. Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study [Internet]. Journal of Chromatography B. 2016 ; 1011 53-61.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1016/j.jchromb.2015.12.049
Artigo de periodico
CR-LAAO antileukemic effect against Bcr-Abl+ cells is mediated by apoptosis and hydrogen peroxide (2016)
Burin, Sandra Mara; Ghisla, Sandro; Ouchida, Amanda Tomie; Aissa, Alexandre Ferro; Coelho, Maria Gabriela Berzoti; Costa, Tássia Rafaella; Marsola, Ana Paula Zambuzi Cardoso; Simões, Belinda Pinto; Antunes, Lusânia Maria Greggi; Curti, Carlos; Sampaio, Suely Vilela; Castro, Fabíola Attié de
Source: International Journal of Biological Macromolecules. Unidades: FMRP, FCFRP
Subjects: APOPTOSE, LEUCEMIA MIELOIDE, NEOPLASIAS, VENENOS DE ORIGEM ANIMAL, COBRAS, VIPERIDAE, CITOTOXICIDADE IMUNOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURIN, Sandra Mara et al. CR-LAAO antileukemic effect against Bcr-Abl+ cells is mediated by apoptosis and hydrogen peroxide. International Journal of Biological Macromolecules, v. 86, p. 309-320, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ijbiomac.2016.01.069. Acesso em: 07 jun. 2024.
APA
Burin, S. M., Ghisla, S., Ouchida, A. T., Aissa, A. F., Coelho, M. G. B., Costa, T. R., et al. (2016). CR-LAAO antileukemic effect against Bcr-Abl+ cells is mediated by apoptosis and hydrogen peroxide. International Journal of Biological Macromolecules, 86, 309-320. doi:10.1016/j.ijbiomac.2016.01.069
NLM
Burin SM, Ghisla S, Ouchida AT, Aissa AF, Coelho MGB, Costa TR, Marsola APZC, Simões BP, Antunes LMG, Curti C, Sampaio SV, Castro FA de. CR-LAAO antileukemic effect against Bcr-Abl+ cells is mediated by apoptosis and hydrogen peroxide [Internet]. International Journal of Biological Macromolecules. 2016 ; 86 309-320.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1016/j.ijbiomac.2016.01.069
Vancouver
Burin SM, Ghisla S, Ouchida AT, Aissa AF, Coelho MGB, Costa TR, Marsola APZC, Simões BP, Antunes LMG, Curti C, Sampaio SV, Castro FA de. CR-LAAO antileukemic effect against Bcr-Abl+ cells is mediated by apoptosis and hydrogen peroxide [Internet]. International Journal of Biological Macromolecules. 2016 ; 86 309-320.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1016/j.ijbiomac.2016.01.069
Artigo de periodico
Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine (2016)
Castro, Francine Attié de; Simões, Belinda Pinto; Godoy, Ana Leonor Pardo Campos; Trigo, Fernanda Manuela Bertagnoli; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: CÉLULAS-TRONCO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Francine Attié de et al. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine. The Journal of Clinical Pharmacology, v. 56, n. 12, p. 1555-1562, 2016Tradução . . Disponível em: https://doi.org/10.1002/jcph.758. Acesso em: 07 jun. 2024.
APA
Castro, F. A. de, Simões, B. P., Godoy, A. L. P. C., Trigo, F. M. B., Coelho, E. B., & Lanchote, V. L. (2016). Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine. The Journal of Clinical Pharmacology, 56( 12), 1555-1562. doi:10.1002/jcph.758
NLM
Castro FA de, Simões BP, Godoy ALPC, Trigo FMB, Coelho EB, Lanchote VL. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 12): 1555-1562.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1002/jcph.758
Vancouver
Castro FA de, Simões BP, Godoy ALPC, Trigo FMB, Coelho EB, Lanchote VL. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 12): 1555-1562.[citado 2024 jun. 07 ] Available from: https://doi.org/10.1002/jcph.758

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Indexado em